Catastrophic heparin-induced thrombocytopenia/thrombosis syndrome related to the use of a Port-A-Cath in a breast cancer patient receiving chemotherapy

By Dai Ming-Shen   Hsieh An-Tie   Chao Tsu-Yi  

Supportive Care in Cancer, Vol. 12, Iss. 7, 2004-07 ,pp. : 537-539

Springer Publishing Company

Access to resources Recommend Favorite

Residual Breast Tissue after Mastectomy: How Often and Where Is It Located?

By Griepsma M.   Roy van Zuidewijn D.   Grond A.   Siesling S.   Groen H.   Bock G.  

Annals of Surgical Oncology, Vol. 21, Iss. 4, 2014-04 ,pp. : 1260-1266

Springer Publishing Company

Access to resources Recommend Favorite

Drug switch because of treatment-related adverse side effects in endocrine adjuvant breast cancer therapy: how often and how often does it work?

By Güth Uwe  

Breast Cancer Research and Treatment, Vol. 129, Iss. 3, 2011-10 ,pp. : 799-807

Springer Publishing Company

Access to resources Recommend Favorite

Dermatofibrosarcoma Protuberans: How Wide Should We Resect?

By Farma Jeffrey  

Annals of Surgical Oncology, Vol. 17, Iss. 8, 2010-08 ,pp. : 2112-2118

Springer Publishing Company

Access to resources Recommend Favorite

Breast self-examination: who teaches it, who is taught, and how often? (United States)

By Nekhlyudov L.  

Cancer Causes and Control, Vol. 13, Iss. 4, 2002-05 ,pp. : 343-351

Springer Publishing Company

Access to resources Recommend Favorite